Convergence Investment Partners’s Magellan Health Services, Inc. MGLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-3,301
Closed -$205K – 333
2019
Q3
$205K Buy
+3,301
New +$220K 0.06% 211
2018
Q3
– Sell
-19,791
Closed -$1.9M – 375
2018
Q2
$1.9M Sell
19,791
-26,798
-58% -$2.57M 0.27% 137
2018
Q1
$4.99M Buy
46,589
+31,404
+207% +$3.15M 0.65% 28
2017
Q4
$1.47M Buy
+15,185
New +$1.34M 0.2% 192
2016
Q3
– Sell
-26,429
Closed -$1.74M – 404
2016
Q2
$1.74M Hold
26,429
– – 0.24% 159
2016
Q1
$1.79M Buy
+26,429
New +$1.59M 0.21% 165
2014
Q3
– Sell
-22,630
Closed -$1.41M – 442
2014
Q2
$1.41M Buy
22,630
+3,740
+20% +$220K 0.19% 180
2014
Q1
$1.12M Sell
18,890
-36,128
-66% -$2.15M 0.17% 180
2013
Q4
$3.3M Buy
55,018
+17,665
+47% +$1.05M 0.54% 39
2013
Q3
$2.24M Buy
37,353
+5,165
+16% +$299K 0.47% 66
2013
Q2
$1.8M Buy
+32,188
New +$1.69M 0.47% 67

Other funds holding MGLN

Convergence Investment Partners's MGLN Position: Q4 2019 in Review

Convergence Investment Partners sold out of Magellan Health Services, Inc. (MGLN) in Q4 2019, closing a stake of 3,301 shares — an estimated $205K sold.

Convergence Investment Partners first reported a position in MGLN in Q2 2013 and held it in 11 quarters. The position peaked at $4.99M in Q1 2018. 207 funds tracked by Wall St. Rank hold MGLN as of Q4 2019.

  • Convergence Investment Partners reported no remaining Magellan Health Services, Inc. position as of Q4 2019 after selling out during the quarter.
  • Convergence Investment Partners sold 3,301 Magellan Health Services, Inc. shares in Q4 2019, an estimated $205K.
  • Convergence Investment Partners first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 11 quarters.
  • Convergence Investment Partners's Magellan Health Services, Inc. position peaked at $4.99M in Q1 2018.
  • 207 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q4 2019.

Based on Convergence Investment Partners's 13F filing for Q4 2019, filed 22 Jan 2020.